scholarly journals Pancreatic Transcription Factors Containing Protein Transduction Domains Drive Mouse Embryonic Stem Cells towards Endocrine Pancreas

PLoS ONE ◽  
2012 ◽  
Vol 7 (5) ◽  
pp. e36481 ◽  
Author(s):  
Maria João Lima ◽  
Hilary M. Docherty ◽  
Yuanxiao Chen ◽  
Ludovic Vallier ◽  
Kevin Docherty
Cell Cycle ◽  
2019 ◽  
Vol 18 (20) ◽  
pp. 2697-2712 ◽  
Author(s):  
Fabrice Gonnot ◽  
Diana Langer ◽  
Pierre-Yves Bourillot ◽  
Nathalie Doerflinger ◽  
Pierre Savatier

PLoS ONE ◽  
2013 ◽  
Vol 8 (1) ◽  
pp. e54243 ◽  
Author(s):  
Fabien Delaspre ◽  
Mohammad Massumi ◽  
Marta Salido ◽  
Bernat Soria ◽  
Philippe Ravassard ◽  
...  

2008 ◽  
Vol 389 (7) ◽  
Author(s):  
Manal Bosnali ◽  
Frank Edenhofer

Abstract The transcription factors Oct4 and Sox2 are two of the main regulators of pluripotency in embryonic stem cells. Since the importance of non-genetic modification is continually increasing, particularly for therapeutic application of manipulated cells, the aim of the present study was to generate cell-permeant Oct4 and Sox2 proteins for the direct cellular delivery of active proteins. Protein transduction allowing cellular manipulation to circumvent genetic modification of target cells has recently been developed. We present a new expression vector system, pSESAME, that facilitates the generation of transducible proteins. Using pSESAME, both Oct4 and Sox2 were genetically fused with a TAT protein transduction domain that promotes cellular penetration. The recombinant purified Oct4 and Sox2 fusion proteins display DNA-binding properties comparable to their endogenous counterparts, and exhibit cellular entry and the ability to modulate the transcriptional machinery maintaining pluripotency of mouse embryonic stem cells. In a rescue assay we demonstrate that transducible Oct4 and Sox2 fusion proteins can compensate knockdown of Pou5f1 and Sox2, respectively. This study provides powerful tools for the modulation of stem cell properties without genetic interference.


2012 ◽  
Vol 113 (4) ◽  
pp. 1122-1131 ◽  
Author(s):  
Nyam-Osor Chimge ◽  
Aleksandr V. Makeyev ◽  
Sabine J. Waigel ◽  
Badam Enkhmandakh ◽  
Dashzeveg Bayarsaihan

2019 ◽  
Author(s):  
Fabrice Gonnot ◽  
Diana Langer ◽  
Pierre-Yves Bourillot ◽  
Nathalie Doerflinger ◽  
Pierre Savatier

AbstractContinuous, non-cell cycle-dependent expression of cyclin E is a characteristic feature of mouse embryonic stem cells (ESCs). We studied the 5’ regulatory region of Cyclin E, also known as Ccne1, and identified binding sites for transcription factors of the naïve pluripotency network, including Esrrb, Klf4, and Tfcp2l1 within 1 kilobase upstream of the transcription start site. Luciferase assay and chromatin immunoprecipitation-quantitative polymerase chain reaction (ChiP–qPCR) study highlighted one binding site for Esrrb that is essential to transcriptional activity of the promoter region, and three binding sites for Klf4 and Tfcp2l1. Knockdown of Esrrb, Klf4, and Tfcp2l1 reduced Cyclin E expression whereas overexpression of Esrrb and Klf4 increased it, indicating a strong correlation between the expression level of these factors and that of cyclin E. We observed that cyclin E overexpression delays differentiation induced by Esrrb depletion, suggesting that cyclin E is an important target of Esrrb for differentiation blockade. We observed that mESCs express a low level of miR-15a and that transfection of a miR-15a mimic decreases Cyclin E mRNA level. These results lead to the conclusion that the high expression level of Cyclin E in mESCs can be attributed to transcriptional activation by Esrrb as well as to the absence of its negative regulator, miR-15a.


Stem Cells ◽  
2008 ◽  
Vol 26 (1) ◽  
pp. 3-16 ◽  
Author(s):  
Ioannis Serafimidis ◽  
Irini Rakatzi ◽  
Vasso Episkopou ◽  
Mina Gouti ◽  
Anthony Gavalas

Sign in / Sign up

Export Citation Format

Share Document